Clinical outcomes of patients with acute myeloid leukemia: evaluation of genetic and molecular findings in a real-life setting

Blood. 2015 Oct 8;126(15):1863-5. doi: 10.1182/blood-2015-07-657551. Epub 2015 Aug 28.

Affiliations

¹ Department of Genetics, Federal University of Pernambuco, Recife, Brazil.
² Department of Internal Medicine, Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil.
³ Department of Genetics, Federal University of Pernambuco, Recife, Brazil Department of Internal Medicine, Hematology and Hemotherapy Foundation of Pernambuco, Recife, Brazil.
⁴ Department of Internal Medicine, Hematology and Hemotherapy Foundation of Pernambuco, Recife, Brazil.

PMID: 26320101
DOI: 10.1182/blood-2015-07-657551

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Biomarkers, Tumor / genetics*
Cytarabine / administration & dosage
Cytogenetic Analysis
Etoposide / administration & dosage
Female
Follow-Up Studies
Humans
Idarubicin / administration & dosage
Leukemia, Myeloid, Acute / drug therapy
Leukemia, Myeloid, Acute / genetics
Leukemia, Myeloid, Acute / mortality*
Leukemia, Myeloid, Acute / pathology
Male
Middle Aged
Mutation / genetics*
Neoplasm Staging
Nuclear Proteins / genetics*
Nucleophosmin
Prognosis
Survival Rate
Thioguanine / administration & dosage
Young Adult
fms-Like Tyrosine Kinase 3 / genetics*

Substances

Biomarkers, Tumor
Nuclear Proteins
Cytarabine
Nucleophosmin
Etoposide
FLT3 protein, human
fms-Like Tyrosine Kinase 3
Thioguanine
Idarubicin